Erik Zhang
Oncology Hematology Care(US)University of Cincinnati(US)University of Cincinnati Medical Center(US)
Publications by Year
Research Areas
Tuberous Sclerosis Complex Research, PI3K/AKT/mTOR signaling in cancer, Eosinophilic Disorders and Syndromes, Eicosanoids and Hypertension Pharmacology, Computational Drug Discovery Methods
Most-Cited Works
- → Post-transcriptional Regulation of De Novo Lipogenesis by mTORC1-S6K1-SRPK2 Signaling(2017)209 cited
- → Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells(2014)69 cited
- → Folliculin regulates cell-cell adhesion, AMPK, and mTORC1 in a cell-type-specific manner in lung-derived cells(2014)62 cited
- → RETRACTED: Synthetic lethality of combined glutaminase and Hsp90 inhibition in mTORC1-driven tumor cells(2014)58 cited
- → Small‐molecule inhibition of prostaglandin E receptor 2 impairs cyclooxygenase‐associated malignant glioma growth(2019)54 cited
- → Faslodex Inhibits Estradiol-Induced Extracellular Matrix Dynamics and Lung Metastasis in a Model of Lymphangioleiomyomatosis(2013)40 cited